Solitary fibrous tumour

Solitary fibrous tumours (SFT) are a rare neoplasm of mesenchymal origin that comprise less than 2% of all soft tissue tumours. The majority are benign, although up to 20% may be malignant.

For a discussion of specific presentations of SFT, please refer to

Intrathoracic SFT usually presents in the 6th to 7th decades. Extrathoracic SFT occurs in men and women of all ages equally 7.

Although typically asymptomatic, it may present with symptoms and signs related to extrinsic compression of adjacent organs. Rarely solitary fibrous tumours result in non-islet cell tumor hypoglycemia (NICTH) as a result of secretion of insulin-like growth factor-2 (IGF-2) 4-7,11. Rarer still is acromegaly 11.

The majority of solitary fibrous tumours occur in an intrathoracic location but up to one third may occur in extrathoracic locations, and as such they may be encountered essentially anywhere, including 7:

  • pleura
  • spinal cord 2-3
  • dura
  • head and neck
  • extremities
  • abdominal parenchymal organs
  • retroperitoneum
  • peritoneum
  • pelvic organs

SFT most likely arises from submesothelial fibroblasts and used to be included in haemangiopericytoma spectrum 10.

At histology, a collagenous matrix with arrays of spindle cells is usually seen. Areas of necrosis, cystic or myxoid change, calcification, hemorrhage, increased vascularity, atypia, or malignancy may also be seen 7-8.

Immunohistochemical analysis can play an important role in the diagnosis and management 12:

  • ~75% of benign solitary fibrous tumors of the thorax stain for CD34, a marker for normal endothelium and vascular tumours
  • B-cell lymphoma 2 protein (Bcl-2), a marker of terminal differentiation, and vimentin are also positive in the majority of benign solitary fibrous tumours
  • cytokeratin, S-100, and p53 proteins have shown increased expression in malignant solitary fibrous tumours

CT reveals a well-circumscribed, smooth, lobulated soft tissue mass that may contain scattered calcifications. Smaller tumors tend to enhance homogeneously, whereas larger lesions may have central tubular or rounded low-attenuation areas due to cystic or necrotic change.

On MRI, benign solitary fibrous tumours usually has relatively homogeneous low-to-intermediate signal intensity relative to skeletal muscle on both T1-weighted imaging and T2-weighted imaging because of fibrous tissue, as well as intense enhancement.

In addition, there may be areas of subacute haemorrhage that have high T1-weighted signal intensity, as well as non-enhancing cystic or necrotic foci that are more heterogeneous and higher in T2-weighted signal intensity relative to the remainder of the tumour.

However, when a central focus of heterogeneity and variable contrast enhancement is identified in an SFT at CT or MRI, malignant degeneration should be considered 7.

  • benign SFT <10 cm in size typically has a favorable outcome with surgical resection alone
  • SFT >10 cm that also harbors malignant foci, and has positive surgical margins tends to have a poor prognosis despite surgical treatment
    • optimal adjuvant therapy for this group is unknown, and close-interval follow-up is advised because there is an increased incidence of local recurrence
Share article

Article information

rID: 21592
Tag: cases
Synonyms or Alternate Spellings:
  • Solitary fibrous neoplasm
  • Solitary fibrous tumours
  • Solitary fibrous tumor
  • Solitary fibrous tumors

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Pulmonary angiogr...
    Case 1: pleural SFT
    Drag here to reorder.
  • Drag
    Case 2: SFT of the spinal cord
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.